Entero Healthcare Solutions Limited — PPTs, 12-02-2025: Investor Presentation

**Financial Highlights:** Entero Healthcare achieved consolidated revenue of ₹1,359 crore, reflecting 37% YoY growth, with organic growth at 17%, far exceeding the Indian Pharmaceutical Market's growth rate of 7%. EBITDA for the quarter reached ₹50 crore, increasing 75% YoY, with margins improving from 2.9% to 3.7%. Gross profit margin also rose to 9.8% from 9.1% YoY.

**Strategic Initiatives and Growth Drivers:** The company continues to expand its market presence, increasing its number of warehouses from 78 to 104 and growing its customer base to over 86,200 retailers and 3,200 hospitals. This enhances operational efficiencies and positions Entero as a key player in healthcare distribution.

**Business Developments:** Entero was recognized with the "Excellence in Healthcare Supply Chain & Logistics 2024" award, underscoring its commitment to quality and operational excellence.

**Market Position and Competitive Advantage:** As one of the top three healthcare product distributors in India, Entero is well-positioned to leverage market consolidation trends, supported by its extensive distribution network across 20 states and 492 districts.

**Investor Implications:** The company's strong growth trajectory and strategic initiatives present promising opportunities for investors, indicating a positive outlook as it capitalizes on the consolidation trend in healthcare distribution.